Otherwise, they contend, brand-name drug companies and biotech startups that rely on money from venture capital firms would have little incentive to ...
News
- How North America trade deal dealt a setback to Big Pharma
- Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ... at the San Antonio Breast Cancer Symposium held December 14 – 29, 2019.
- AFAR & the Irene Diamond Fund provide $840000 to 2019 postdoctoral fellows studying aging
... Jia Nie, PhD, Postdoctoral Fellow, University of Texas Health at San Antonio, will study the Effect of Aging and ... that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer.
- After SABCS stunner, Seattle Genetics nabs FDA breakthrough tag for tucatinib
Just a week after posting strong data at the San Antonio Breast Cancer Symposium, Seattle Genetics has nabbed the coveted FDA breakthrough label ...
- New animal model shows effective treatment for latent tuberculosis
San Antonio, Texas (December 17, 2019) - A major goal of tuberculosis (TB) ... Texas Biomed is one of the world's leading independent biomedical ...